Immune Therapy Versus Gene Therapy

Immune modulation is achieved by actively stimulating cellular immunity by increasing endorphin production by feedback phenomenon, late in the night to early morning. These activated cells then attack the cells implicated in various disease states.

This is a topic that everyone who is passionate about his field of specialization would go to any length to defend. However, to a lay person on the street with cancer or with family members affected by cancer, the most important issue is, which of this can put cancer at bay permanently without the daily grind and untold financial, emotional, physical and family hardships that go with the diagnosis!

Gene therapy (the use of DNA to supplement or alter genes in the individual affected) is here to stay although it has not proven to be as effective considering the hype that came with the introduction in 1990 when Ashanti DeSilva was first treated. The prohibitive cost is also of significance as it is not something that was readily available and accessible by the masses.

Immune modulation is achieved by actively stimulating cellular immunity by increasing endorphin production by feedback phenomenon, late in the night to early morning. These activated cells then attack the cells implicated in various disease states. These conditions include HIV, cancer, allergy, resistant Tuberculosis, typhoid, malaria, crohn’s disease, autoimmunity, chronic fatigue, immune dysfunction, multiple sclerosis, autism etc. There are a variety of drugs that have shown promise in this regard. One good example is Low Dose Naltrexone (Lodonal 4.5mg) the observation of which was started by Dr. Bernard Bihari. In our future discussions, more in-depth information about low dose naltrexone would be provided.

Scroll to Top